Structural Basis of Conformational Dynamics in the PROTAC-Induced Protein Degradation

被引:5
|
作者
Zhao, Hongtao [1 ]
机构
[1] AstraZeneca, BioPharmaceut R&D, Resp & Immunol R&I, Med Chem Res & Early Dev, Gothenburg, Sweden
关键词
PROTAC; conformational dynamics; ubiquitylation; degradation; TERNARY COMPLEX-FORMATION; UBIQUITIN-LIGASE;
D O I
10.1002/cmdc.202400171
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pronounced conformational dynamics is unveiled upon analyzing multiple crystal structures of the same proteins recruited to the same E3 ligases by PROTACs, and yet, is largely permissive for targeted protein degradation due to the intrinsic mobility of E3 assemblies creating a large ubiquitylation zone. Mathematical modelling of ternary dynamics on ubiquitylation probability confirms the experimental finding that ternary complex rigidification need not correlate with enhanced protein degradation. Salt bridges are found to prevail in the PROTAC-induced ternary complexes, and may contribute to a positive cooperativity and prolonged half-life. The analysis highlights the importance of presenting lysines close to the active site of the E2 enzyme while constraining ternary dynamics in PROTAC design to achieve high degradation efficiency. Pronounced conformational dynamics of the same proteins recruited to the same E3 ligases by PROTACs are observed in the crystal structures. Mathematical modelling of ternary dynamics on the ubiquitylation probability confirms that ternary complex rigidification need not correlate with enhanced protein degradation. image
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Structural basis for the processive protein degradation by tricorn protease
    Brandstetter, H
    Kim, JS
    Groll, M
    Göttig, P
    Huber, R
    BIOLOGICAL CHEMISTRY, 2002, 383 (7-8) : 1157 - 1165
  • [22] Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)
    Kang, Chung Hyo
    Lee, Dong Ho
    Lee, Chong Ock
    Ha, Jae Du
    Park, Chi Hoon
    Hwang, Jong Yeon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (02) : 542 - 547
  • [23] Estimating the cooperativity of PROTAC-induced ternary complexes using 19F NMR displacement assay
    de Castro, Guilherme Vieira
    Ciulli, Alessio
    RSC MEDICINAL CHEMISTRY, 2021, 12 (10): : 1765 - 1770
  • [24] Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism
    Armando Tripodi
    Cristina Legnani
    Laura Lemma
    Benilde Cosmi
    Gualtiero Palareti
    Veena Chantarangkul
    Pier Mannuccio Mannucci
    Journal of Thrombosis and Thrombolysis, 2010, 30 : 215 - 219
  • [25] Targeted Protein Degradation: Design Considerations for PROTAC Development
    Tran, Nathan L.
    Leconte, Georges A.
    Ferguson, Fleur M.
    CURRENT PROTOCOLS, 2022, 2 (12):
  • [26] Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism
    Tripodi, Armando
    Legnani, Cristina
    Lemma, Laura
    Cosmi, Benilde
    Palareti, Gualtiero
    Chantarangkul, Veena
    Mannucci, Pier Mannuccio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (02) : 215 - 219
  • [27] Structural basis of lentiviral subversion of a cellular protein degradation pathway
    Schwefel, David
    Groom, Harriet C. T.
    Boucherit, Virginie C.
    Christodoulou, Evangelos
    Walker, Philip A.
    Stoye, Jonathan P.
    Bishop, Kate N.
    Taylor, Ian A.
    NATURE, 2014, 505 (7482) : 234 - +
  • [28] Structural basis of lentiviral subversion of a cellular protein degradation pathway
    David Schwefel
    Harriet C. T. Groom
    Virginie C. Boucherit
    Evangelos Christodoulou
    Philip A. Walker
    Jonathan P. Stoye
    Kate N. Bishop
    Ian A. Taylor
    Nature, 2014, 505 : 234 - 238
  • [29] Ligand-induced conformational and structural dynamics changes in Escherichia coli cyclic AMP receptor protein
    Dong, AC
    Malecki, JM
    Lee, L
    Carpenter, JF
    Lee, JC
    BIOCHEMISTRY, 2002, 41 (21) : 6660 - 6667
  • [30] PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy
    Kelm, Jeremy M. M.
    Pandey, Deepti S. S.
    Malin, Evan
    Kansou, Hussein
    Arora, Sahil
    Kumar, Raj
    Gavande, Navnath S. S.
    MOLECULAR CANCER, 2023, 22 (01)